MRI for detecting hidden liver metastases in pancreatic cancer
Part of Cancer, Digestive system clinical trials.
This trial uses an MRI scan to look for small liver metastases that may not be visible on a CT scan in people newly diagnosed with pancreatic cancer. It aims to improve the accuracy of staging before treatment begins.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a new diagnosis of pancreatic cancer confirmed by biopsy or cytology.
- You have had a CT scan showing the tumor in your pancreas.
- You can have an MRI within 3 weeks of that CT scan.
- You have not received any treatment yet for your pancreatic cancer.
- Your initial CT scan did not show that the cancer has spread to your liver, lungs, or other distant organs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new MRI technique that may help predict how well pancreatic cancer treatments will work. You would receive a special substance (called hyperpolarized pyruvate) during a standard MRI scan.
This trial tests whether a special MRI scan can help doctors better plan treatment for people with pancreatic cancer that is borderline able to be removed by surgery. The study will check how the tumor responds to initial treatment before surgery.
This trial studies whether adding an MRI scan improves the selection of people with pancreatic cancer who may benefit from surgery. It focuses on patients without liver spread and with tumors that are borderline or likely removable.
This study tests whether new MRI techniques can better show how pancreatic cancer responds to treatment. It compares standard CT scans with advanced MRI sequences for patients whose cancer has not spread.
This trial studies an MRI technique using a contrast dye (gadopetate/gadolinium) to better look at liver lesions that may be colon cancer spread. It may help doctors more accurately assess which liver tumors are present and guide next steps.
This study tests if a special MRI scan (MRE) can better diagnose pancreatic masses. It may help doctors find and treat pancreatic cancer more accurately.
Hear when a new Pancreatic Ductal Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.